AC IMMUNE SA Gain Loss On Remeasurement Of Net Defined Benefit Liability Asset
AC IMMUNE SA (ACIU) reported Gain Loss On Remeasurement Of Net Defined Benefit Liability Asset of -CHF 1.35 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-13.
Financial Statements › Income Statement › Other Income
ifrs-full:GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset · last filed 2026-03-13
| Period end | Gain Loss On Remeasurement Of Net Defined Benefit Liability Asset 12 month |
|---|---|
| 2025-12-31 | -1.35M CHF 20-F · filed 2026-03-13 |
| 2024-12-31 | -3.08M CHF 20-F · filed 2026-03-13 |
| 2023-12-31 | -1.67M CHF 20-F · filed 2026-03-13 |
| 2022-12-31 | 4.43M CHF 20-F · filed 2025-03-13 |
| 2021-12-31 | 956.00K CHF 20-F · filed 2024-03-14 |
| 2020-12-31 | 726.00K CHF 20-F · filed 2023-03-16 |